Free Trial

Telomir Pharmaceuticals (TELO) Institutional Ownership

Telomir Pharmaceuticals logo
$1.26 -0.01 (-0.79%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$1.25 -0.01 (-0.40%)
As of 05/15/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)

Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$596.54K
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$481.19K
Get TELO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TELO Institutional Buying and Selling by Quarter

Telomir Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/13/2026 World Investment Advisors35,437$47K0.0%N/A0.103%
2/18/2026XTX Topco Ltd39,712$53K0.0%N/A0.116%
2/18/2026Millennium Management LLC166,975$222K0.0%-24.9%0.486%
2/9/2026Geode Capital Management LLC223,549$297K0.0%+14.0%0.650%
2/4/2026 World Investment Advisors35,437$47K0.0%N/A0.103%
11/17/2025Millennium Management LLC222,404$309K0.0%-10.2%0.647%
11/14/2025 Raymond James Financial Inc.75,340$105K0.0%+4,101.9%0.219%
11/10/2025 OneDigital Investment Advisors LLC23,000$32K0.0%+64.3%0.071%
11/7/2025Vanguard Group Inc.1,101,752$1.53M0.0%-1.5%3.413%
10/15/2025 Praetorian Wealth Management Inc.20,000$28K0.0%N/A0.062%
8/14/2025 Jane Street Group LLC49,556$62K0.0%N/A0.167%
8/14/2025Qube Research & Technologies Ltd26,509$33K0.0%N/A0.089%
8/13/2025Marshall Wace LLP75,770$95K0.0%N/A0.255%
8/8/2025Geode Capital Management LLC196,880$246K0.0%-54.1%0.662%
8/1/2025 Y Intercept Hong Kong Ltd64,423$81K0.0%N/A0.216%
6/27/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/16/2025Goldman Sachs Group Inc.32,282$104K0.0%-36.1%0.108%
5/13/2025HighTower Advisors LLC43,000$139K0.0%N/A0.144%
5/12/2025Nuveen LLC24,990$81K0.0%N/A0.084%
4/29/2025Bank of New York Mellon Corp91,353$295K0.0%+26.4%0.307%
2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036%
2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023%
2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049%
2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510%
2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097%
2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101%
2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034%
2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390%
2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139%
2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032%
2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050%
2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157%
2/4/2025Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244%
1/30/2025Rhumbline Advisers8,600$35K0.0%+105.9%0.029%
11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806%
11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024%
11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122%
10/21/2024Suncoast Equity Management51,194$329K0.0%+109.9%0.173%
SpaceX just filed. The clock is ticking. (Ad)

Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just revealed 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - are competing for a role in what Wall Street is calling 'Project Apex,' a potential $1.75 trillion listing Bloomberg has dubbed the biggest of all time. Dr. Mark Skousen, Macroeconomic Strategist at The Oxford Club, says a pre-IPO 'backdoor' entry still exists - and nearly 15,000 investors have already accessed his free recommendation. June is the reported target date, and the window is narrowing.tc pixel

Get Dr. Skousen's free SpaceX pre-IPO recommendation before June
8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049%
7/26/2024Bank of New York Mellon Corp50,165$241K0.0%N/A0.169%
5/2/2024Suncoast Equity Management24,391$126K0.0%N/A0.082%


TELO Institutional Ownership - Frequently Asked Questions

During the previous two years, 32 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($1.53M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Geode Capital Management LLC ($297K), Bank of New York Mellon Corp ($295K), State Street Corp ($232K), and Millennium Management LLC ($222K).Learn more on Telomir Pharmaceuticals' institutional investors.

Of the 29 institutional investors that purchased Telomir Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($374.84K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Marshall Wace LLP ($75.77K), Raymond James Financial Inc. ($73.55K), World Investment Advisors ($70.87K), and Y Intercept Hong Kong Ltd ($64.42K).

Institutional investors have bought a total of 456,910 shares in the last 24 months. This purchase volume represents approximately $596.54K in transactions.

The following institutional investors have sold Telomir Pharmaceuticals stock in the last 24 months: Geode Capital Management LLC ($232.37K), Millennium Management LLC ($80.72K), Goldman Sachs Group Inc. ($18.25K), and Vanguard Group Inc. ($16.47K).

Institutional investors have sold a total of 347,818 shares in the last 24 months. This volume of shares sold represents approximately $481.19K in transactions.



This page (NASDAQ:TELO) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners